Michael E. Prevoznik - Nov 29, 2024 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Signature
Sean D. Mersten, Attorney in Fact for Michael E. Prevoznik
Stock symbol
DGX
Transactions as of
Nov 29, 2024
Transactions value $
-$5,731,302
Form type
4
Date filed
12/2/2024, 04:43 PM
Previous filing
Sep 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DGX Common Stock Options Exercise $3.04M +35.1K +91.34% $86.63 73.6K Nov 29, 2024 Direct F1
transaction DGX Common Stock Sale -$488K -3.01K -4.09% $162.26 70.6K Nov 29, 2024 Direct F1, F2
transaction DGX Common Stock Sale -$5.24M -32.1K -45.51% $163.15 38.5K Nov 29, 2024 Direct F1, F3
holding DGX Common Stock 5.62K Nov 29, 2024 401(k)/SDCP F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DGX Non-Qualifed Stock Option (right to buy) Options Exercise -$3.04M -35.1K -100% $86.63 0 Nov 29, 2024 Common Stock 35.1K $86.63 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
F2 This transaction was executed in multiple trades at prices ranging from $161.690 to $162.680. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $162.705 to $163.615. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
F5 The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.